Literature DB >> 27575657

A design space exploration for control of Critical Quality Attributes of mAb.

Hemlata Bhatia1, Erik Read2, Cyrus Agarabi2, Kurt Brorson2, Scott Lute2, Seongkyu Yoon3.   

Abstract

A unique "design space (DSp) exploration strategy," defined as a function of four key scenarios, was successfully integrated and validated to enhance the DSp building exercise, by increasing the accuracy of analyses and interpretation of processed data. The four key scenarios, defining the strategy, were based on cumulative analyses of individual models developed for the Critical Quality Attributes (23 Glycan Profiles) considered for the study. The analyses of the CQA estimates and model performances were interpreted as (1) Inside Specification/Significant Model (2) Inside Specification/Non-significant Model (3) Outside Specification/Significant Model (4) Outside Specification/Non-significant Model. Each scenario was defined and illustrated through individual models of CQA aligning the description. The R(2), Q(2), Model Validity and Model Reproducibility estimates of G2, G2FaGbGN, G0 and G2FaG2, respectively, signified the four scenarios stated above. Through further optimizations, including the estimation of Edge of Failure and Set Point Analysis, wider and accurate DSps were created for each scenario, establishing critical functional relationship between Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs). A DSp provides the optimal region for systematic evaluation, mechanistic understanding and refining of a QbD approach. DSp exploration strategy will aid the critical process of consistently and reproducibly achieving predefined quality of a product throughout its lifecycle.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critical process parameter; Critical quality attribute; Design space

Mesh:

Substances:

Year:  2016        PMID: 27575657     DOI: 10.1016/j.ijpharm.2016.08.046

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

1.  Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach.

Authors:  Jianqi Nie; Yang Sun; Fei Han; Yankun Yang; Xiuxia Liu; Chunli Liu; Ye Li; Zhonghu Bai
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

2.  Hybridoma cell-culture and glycan profile dataset at various bioreactor conditions.

Authors:  Hemlata Bhatia; Erik Read; Cyrus Agarabi; Kurt Brorson; Scott Lute; Seongkyu Yoon
Journal:  Data Brief       Date:  2016-10-13

3.  Improved Understanding of the High Shear Wet Granulation Process under the Paradigm of Quality by Design Using Salvia miltiorrhiza Granules.

Authors:  Yi Zhang; Brian Chi-Yan Cheng; Wenjuan Zhou; Bing Xu; Xiaoyan Gao; Yanjiang Qiao; Gan Luo
Journal:  Pharmaceutics       Date:  2019-10-09       Impact factor: 6.321

Review 4.  Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.

Authors:  Leena Peltonen
Journal:  Pharmaceutics       Date:  2018-07-25       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.